Antigen-Specific Immunological Memory via In Vitro Lymphocyte Education
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional vaccination methods using live attenuated or killed whole pathogens and chemicals like thimerosal, formaldehyde, and aluminum can cause adverse reactions and are shunned by certain groups, leading to concerns about herd immunity and the effectiveness of immunological memory establishment, especially for pathogens like measles and whooping cough.
Innovation Solution
Generating antigen-specific memory lymphocytes in vitro, which are educated to recognize and respond to specific pathogens without causing an immune response upon inoculation, and administered in a solution free from thimerosal, formaldehyde, and aluminum, allowing for targeted immunological memory without the use of whole killed or attenuated pathogens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional vaccines using live attenuated or killed whole pathogens are administered, then immunological memory is established, but adverse immune responses and chemical exposure occur
Solution Approach 1:
The vaccine is segmented into two distinct components: (1) antigen-presenting cells (dendritic cells or macrophages) that present processed pathogen antigens, and (2) specific pathogens or pathogen components that are separate from the delivery vehicle. This segmentation allows the immune system to receive antigen stimulation without exposure to harmful whole pathogens or chemicals, thereby establishing immunological memory while avoiding adverse responses.
Solution Approach 2:
The harmful elements (live attenuated or killed whole pathogens and chemicals like thimerosal, formaldehyde, and aluminum) are extracted and removed from the vaccine formulation. Only the essential antigenic components are retained and presented by antigen-presenting cells, eliminating the harmful factors while preserving the immunological memory-establishing function.
2Stability of the object's composition
If certain chemicals (thimerosal, formaldehyde, aluminum) are included in vaccine solutions, then vaccine stability and delivery are improved, but public acceptance and safety concerns deteriorate
Solution Approach 1:
The harmful chemicals (thimerosal, formaldehyde, and aluminum) are completely extracted and removed from the vaccine solution. The vaccine is reformulated to use only biocompatible components, including antigen-presenting cells and specific pathogens or pathogen components, thereby eliminating safety concerns and improving public acceptance while maintaining vaccine stability through alternative delivery mechanisms.
Solution Approach 2:
The vaccine uses a composite formulation consisting of antigen-presenting cells (dendritic cells or macrophages) combined with specific pathogens or pathogen components. This composite structure provides both stability and biocompatibility, replacing the need for harmful chemicals while ensuring vaccine effectiveness and public acceptance.
3Productivity
If whole killed or attenuated pathogens are used in vaccines, then broad immune response is triggered, but immune reactions including swelling, pain, and seizures occur
Solution Approach 1:
The vaccine system is segmented into antigen-presenting cells that process and present only specific antigenic components to the immune system. This segmentation allows for targeted immune activation without the non-specific stimulation caused by whole pathogens, thereby triggering necessary immune responses while avoiding harmful reactions such as swelling, pain, and seizures.
Solution Approach 2:
The vaccine provides localized and specific antigen stimulation through antigen-presenting cells that present only the relevant pathogen antigens. This localized quality ensures that the immune response is focused on the specific pathogen threat without the diffuse and harmful immune activation caused by whole killed or attenuated pathogens, preventing adverse reactions while maintaining effective immunity.
Data Source
AI summary
The disclosed method provides a novel approach of generating antigen-specific Immunological Memory in a subject which consists primarily of extracting and purifying monocytes, naive T and B lymphocytes from a subject and educating said lymphocytes against a pathogen in vitro until a population of antigen-specific memory lymphocytes are generated with a memory against an infectious agent. Said memory lymphocytes are administered to a subject in a solution which consist primarily of blood plasma derived from said subject. In embodiments, one will see a vaccine approach wherein said vaccine excludes the inoculation of attenuated or killed whole pathogens, where inoculation of said vaccine does not illicit an immune response upon inoculation, and where said vaccine excludes chemicals such as thimerosal, formaldehyde, and aluminum which is all shunned by anti-vaccinators.